-
Uncategorized6 months ago
Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug program. But for Valneva CEO...
-
Uncategorized6 months agoSTAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’re officially in...
-
Uncategorized6 months ago
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
-
Uncategorized6 months agoPartnership set to make therapies ‘reach patients sooner’
A new partnership could accelerate clinical trials and bring therapies to patients sooner. Clinical research organisation ICON has partnered with Advarra to introduce a new ‘research-ready’ site network...
-
Uncategorized6 months ago
FDA delays decision on Orca Bio cell therapy after filing more manufacturing data
The FDA has postponed its deadline on whether to approve Orca Bio’s T cell therapy by three months to July 6. The agency was expected to...
-
Uncategorized6 months ago
FDA, after turbulent year, leaves drugmakers guessing on its direction
Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator is as unpredictable as it’s ever been. Read More
-
Uncategorized6 months agoSupreme Court rules against conversion therapy ban
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. As you hopefully already know, STAT...
-
Uncategorized6 months ago
Oric to advance prostate cancer drug to Phase 3, but combo choice raises doubts
Oric to advance prostate cancer drug to Phase 3, but combo choice raises doubts
-
Uncategorized6 months agoExpanding the Toolbox for Mammalian Genome Engineering
Sponsored content brought to you by Across biomanufacturing, disease modeling, synthetic biology, and cell therapy development, researchers increasingly need to insert large DNA constructs into mammalian...
-
Uncategorized6 months agoDetecting Disease at Its Molecular Origin
Sponsored content brought to you by Credit: Garage Brain Science Even for most of modern medicine, the beginning of a disease is synonymous with symptoms. A...
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
Deep dive: Psychedelics back on FDA’s doorstep
‘Patients are not a renewable resource’: Rethinking rare disease R&D
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
